Project BioShield: Authorities, Appropriations, Acquisitions, and Issues for Congress
LIBRARY OF CONGRESS WASHINGTON DC CONGRESSIONAL RESEARCH SERVICE
Pagination or Media Count:
Many potential chemical, biological, radiological, and nuclear CBRN terrorism agents lack available medical countermeasures. In 2003, President Bush proposed Project BioShield to address this need. The Project BioShield Act became law in July 2004 P.L. 108-276. This law has three main provisions 1 relaxing regulatory requirements for some CBRN terrorism-related spending, including hiring and awarding research grants 2 guaranteeing a federal government market for new CBRN medical countermeasures and 3 permitting emergency use of unapproved countermeasures. The Department of Health and Human Services HHS has used each of these authorities. The HHS used expedited review authorities to approve 5 contracts and 47 grants related to CBRN countermeasure research and development. The HHS used the authority to guarantee a government market to obligate approximately 2 billion to acquire countermeasures against anthrax, botulism, radiation, and smallpox. The HHS has also employed the emergency use authority several times, including allowing young children with H1N1 swine influenza to receive specific antiviral drugs.
- Government and Political Science
- Medicine and Medical Research
- Unconventional Warfare